Faculty Publications

Lewis N, Cohen RB, Nishida Y, Hurwitz HI, Arrowwood C, Uronis HE, Gamza F, Longley C, Buchbinder A, Figueroa J

Phase I, pharmacokinetic (PK), dose-escalation study of EZN-2968, a novel hypoxia-inducible factor-1 alpha (HIF-1a) antagonist, administered weekly in patients (pts) with solid tumours

EJC Supplements. 2008;6(12):125.

Abstract